학술논문
23P Immunosenescence (iSenescence) correlates with progression (PD) to PD-(L)1 inhibitors (IO) and not to platinum-chemotherapy (PCT) in advanced non-small cell lung cancer (aNSCLC) patients (pts).
Document Type
Article
Author
Source
Subject
*PEMETREXED
*NON-small-cell lung carcinoma
*IMMUNOSENESCENCE
*MOLECULAR oncology
*
*
*
Language
ISSN
0923-7534